| Trials | All | ACT | AHT | APT | CEA | GL | HRT | Statins | Vitamins | P |
---|---|---|---|---|---|---|---|---|---|---|---|
All |  |  | N = 8 | N = 8 | N = 7 | N = 3 | N = 1 | N = 2 | N = 4 | N = 2 |  |
Primary (%) | 15 | Â | 4 (36.7%) | 6 (40.0%) | 0 | 1 (6.7%) | 1 (6.7%) | 2 (13.3%) | 1 (6.7%) | 0 | Â |
Secondary (%) | 20 | Â | 4 (20.0%) | 2 (10.0%) | 7 (35.0%) | 2 (10.0%) | 0 | 0 | 3 (15.0%) | 2 (10.0%) | Â |
Baseline | |||||||||||
 Number | 35 | 254,223 | 54,713 | 81,058 | 39,714 | 5074 | 10,251 | 27,347 | 24,222 | 11,844 |  |
 Age | 35 | 65.1 (30.5) | 69.0 (11.7) | 64.6 (51.9) | 66.0 (9.6) | 66.6 (8.2) | 62.8 (6.6) | 63.4 (7.2) | 59.3 (8.1) | 63.7 (12.1) | < 0.0001 |
 Sex, Female (%) | 35 | 117,222 (46.1%) | 21,063 (38.5%) | 39,213 (48.4%) | 14,697 (37.0%) | 2711 (53.4%) | 3952 (38.6%) | 27,347 (100%) | 3916 (16.2%) | 4323 (36.5%) | < 0.0001†|
Medical History (%) | |||||||||||
 Diabetes | 34 | 51,131 (20.1%) | 7030 (12.9%) | 17,143 (21.2%) | 8897 (22.4%) | 1135 (22.4%) | 10,251 (100%) | 1980 (7.2%) | 1725 (7.1%) | 2970 (25.3%) | < 0.0001‡ |
 Hypertension | 32 | 153,427 (69.6%) | 22,771 (67.0%) | 76,550 (94.5%) | 25,871 (65.2%) | 3212 (63.3%) | – | 8433 (34.0%) | 8141 (33.6%) | 8449 (72.0%) | < 0.0001 |
 Hyperlipidaemia | 17 | 27,627 (29.8%) | 96 (9.6%) | 1019 (15.4%) | 14,757 (37.3%) | 1291 (37.8%) | – | 3366 (13.7%) | 4444 (40.2%) | 2654 (41.7%) | < 0.0001 |
 IHD | 12 | 27,850 (30.6%) | – | 8813 (24.0%) | 6724 (20.7%) | 1970 (38.8%) | – | – | 9014 (100%) | 1329 (17.0%) | < 0.0001¥ |
 Stroke | 28 | 21,645 (12.6%) | 3403 (9.6%) | 5375 (13.9%) | 8707 (23.9%) | 717 (21.0%) | 630 (6.1%) | 306 (1.1%) | 369 (4.1%) | 2138 (18.2%) | < 0.0001 |
 MI | 25 | 22,069 (13.6%) | 5073 (14.4%) | 704 (2.1%) | 2720 (7.7%) | 640 (18.8%) | 1590 (15.5%) | 634 (2.3%) | 10,708 (60.8%) | – | < 0.0001 |
 Smoking, Current | 31 | 48,441 (20.9%) | 7030 (21.0%) | 17,515 (21.9%) | 10,211 (25.8%) | 1471 (29.0%) | 1247 (12.2%) | 2831 (10.5%) | 3496 (14.4%) | 4640 (39.5%) | < 0.0001 |
 Alcohol | 12 | 27,897 (41.3%) | 6373 (34.2%) | 4754 (48.0%) | 10,984 (40.5%) | 561 (33.8%) | – | – | 3098 (46.9%) | 2127 (59.4%) | < 0.0001 |
 SBP | 31 | 145.8 (23.1) | 143.5 (27.1) | 155.2 (19.8) | 147.4 (20.2) | 146.1 (19.3) | – | 128.7 (17.6) | 136.5 (18.8) | 141.5 (20.9) | < 0.0001 |
 DBP | 30 | 83.3 (12.0) | 79.5 (12.8) | 87.7 (11.1) | 84.9 (11.7) | 80.1 (10.0) | – | 76.0 (9.2) | 80.3 (10.4) | 81.6 (12.1) | < 0.0001 |
 HR | 14 | 73.1 (13.7) | 75.1 (15.8) | 77.5 (11.6) | 73.2 (12.4) | 73.1 (10.6) | – | – | 67.8 (11.1) | – | < 0.0001 |
Secondary | |||||||||||
 Qualifying event (%) | |||||||||||
  Stroke | 19 | 71,178 (66.4%) | 19,779 (60.9%) | 5632 (85.2%) | 34,071 (85.8%) | 1571 (46.0%) | – | – | – | 10,125 (86.1%) | < 0.0001 |
  MI | 19 | 25,528 (22.9%) | 12,090 (37.2%) | – | – | – | – | – | 1348 (76.3%) | – | < 0.0001 |
  TIA | 19 | 9979 (9.3%) | 347 (1.1%) | 974 (14.7%) | 5497 (13.8%) | 1759 (51.6%) | – | – | – | 1402 (11.9%) | < 0.0001 |
  OTR | 18 | 91.2 (246.2) | 3.2 (12.9) | 418.0 (439.6) | 31.0 (163.5) | 47.9 (43.6) | – | – | 507.4 (317.0) | 60.2 (178.0) | < 0.0001 |